Tapentadol in Chronic Malignant Tumour Related Pain

PHASE3TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
CancerChronic PainPain
Interventions
DRUG

Tapentadol Prolonged Release

Titration to achieve sufficient pain relief to continue with effective analgesia for as long as the participant tolerates and wishes to continue treatment.

Trial Locations (12)

2025

Site 373001, Chisinau

4412

Site 036002, Nyíregyháza

7100

Site 036010, Szekszárd

9700

Site 359004, Shumen

18000

Site 381002, Niš

21204

Site 381001, Kamenitz

85796

Site 048004, Bydgoszcz

362007

Site 007012, Vladikavkaz

500074

Site 040006, Brasov

603140

Site 007007, Nizhny Novgorod

02781

Site 048001, Warsaw

022328

Site 040002, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY